Short answer

Explore novel excipients and employ systematic design methodologies like QbD to optimize drug delivery systems for improved therapeutic outcomes.

Field: Commercial Production
Source: International Journal of Applied Pharmaceutics (2025)
Method: Experimental design and characterization
Evidence: Strong effect

Utilizing starch humate as a novel superdisintegrant in fast-dissolving tablets, guided by Quality by Design principles, significantly enhances the oral bioavailability of Telmisartan. This commercial production research insight is drawn from a 2025 study published in International Journal of Applied Pharmaceutics. Using Experimental design and characterization, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Explore novel excipients and employ systematic design methodologies like QbD to optimize drug delivery systems for improved therapeutic outcomes.

Study

Commercial ProductionNew This WeekStrong effect

Starch Humate as a Novel Superdisintegrant Boosts Telmisartan Bioavailability by 13%

Utilizing starch humate as a novel superdisintegrant in fast-dissolving tablets, guided by Quality by Design principles, significantly enhances the oral bioavailability of Telmisartan.

International Journal of Applied Pharmaceutics · 2025

Key Findings

01Starch humate exhibited favorable flow properties and structural integrity.
02FTIR and DSC confirmed no adverse drug-excipient interactions.
03Optimized tablets with 5% starch humate achieved a disintegration time of 24 seconds and 99.73% cumulative drug dissolution within 10 minutes.
04Pharmacokinetic studies showed a 113.09% relative bioavailability for Telmisartan fast-dissolving tablets formulated with starch humate.

Application

Design takeaway

Explore novel excipients and employ systematic design methodologies like QbD to optimize drug delivery systems for improved therapeutic outcomes.

How to apply

When developing oral solid dosage forms, consider novel excipients that can improve drug release and absorption, and utilize QbD principles to systematically optimize formulation and manufacturing parameters.

Project actions

01When selecting excipients, consider their impact on drug release and bioavailability.
02Employ systematic design of experiments (DoE) to optimize formulation parameters.

Method & Evidence

AimTo investigate the potential of starch humate as a new superdisintegrant for enhancing the oral bioavailability and dissolution efficiency of Telmisartan in fast-dissolving tablets using a Quality by Design methodology.

MethodExperimental design and characterization

ProcedureSorghum starch was isolated and reacted with humic acid to form starch humate. The starch humate was characterized using NMR, SEM, XRD, FTIR, and DSC. A 2³ factorial design was employed to formulate Telmisartan fast-dissolving tablets using starch humate, sodium starch glycolate, and crospovidone as variables. Tablet properties such as disintegration time, cumulative percent drug dissolution, and dissolution efficiency were evaluated. Pharmacokinetic studies were conducted to assess relative bioavailability.

ContextPharmaceutical formulation and drug delivery

Variables

IV["Concentration of starch humate (SH)","Concentration of Sodium Starch Glycolate (SSG)","Concentration of Crospovidone (CP)"]

DV["Disintegration Time (DT)","Cumulative Percent Drug Dissolution (CPDD)","Dissolution Efficiency (DE)","Relative Bioavailability"]

CV["Drug (Telmisartan) amount","Tablet compression force","Tablet hardness","Tablet thickness","Manufacturing method (direct compression)"]

Strengths & Limitations

Strengths

+Utilized a novel, potentially cost-effective superdisintegrant.
+Employed a systematic Quality by Design approach for optimization.

Limitations

The cost-effectiveness and large-scale production feasibility of starch humate would need further investigation for commercial application.

Reliability & validity

The use of multiple characterization techniques (NMR, SEM, XRD, FTIR, DSC) and a factorial design enhances the reliability and validity of the findings regarding starch humate's properties and its impact on tablet performance. Pharmacokinetic studies provide a direct measure of in-vivo efficacy.

Think critically

What are the potential challenges in scaling up the production of starch humate and ensuring its consistent quality for pharmaceutical use?

Design Principles

"Material innovation and systematic process optimization are key to enhancing product performance and efficacy."

This research demonstrates a novel material approach to improving drug delivery, directly impacting therapeutic efficacy and patient outcomes. The application of QbD ensures a robust and reproducible manufacturing process, crucial for commercial viability and regulatory approval.

What This Means for Your Design

Researchers found a new ingredient made from starch that helps medicine dissolve faster in the body, making it work better. They used a smart design method to make sure it worked reliably.

How to use in your project

1.Reference this study when discussing the selection of novel excipients to improve drug delivery or when justifying the use of QbD in pharmaceutical design projects.

Add to My Project

Quick Cite

Paragraph starter

The development of novel excipients, such as starch humate, offers promising avenues for enhancing drug bioavailability and therapeutic efficacy, as demonstrated by its successful application in Telmisartan fast-dissolving tablets (Kumar & Rada, 2025). This approach, guided by Quality by Design principles, ensures a robust and reproducible manufacturing process, critical for commercial viability.

Source

International Journal of Applied Pharmaceutics

QBD APPROACH IN THE ENHANCEMENT OF ORAL BIOAVAILABILITY TELMISARTAN FAST DISSOLVING TABLETS EMPLOYING STARCH HUMATE AS A NEW SUPERDISINTEGRANT

journal · 2025

View source

Questions About This Research

What does the research say about starch humate as a novel superdisintegrant boosts telmisartan bioavailability by 13%?: Explore novel excipients and employ systematic design methodologies like QbD to optimize drug delivery systems for improved therapeutic outcomes. Evidence: International Journal of Applied Pharmaceutics (2025).
Why does "Starch Humate as a Novel Superdisintegrant Boosts Telmisartan Bioavailability by 13%" matter for design?: This research demonstrates a novel material approach to improving drug delivery, directly impacting therapeutic efficacy and patient outcomes. The application of QbD ensures a robust and reproducible manufacturing process, crucial for commercial viability and regulatory approval.
How can designers apply this research?: Explore novel excipients and employ systematic design methodologies like QbD to optimize drug delivery systems for improved therapeutic outcomes.
What were the main findings?: Starch humate exhibited favorable flow properties and structural integrity.. FTIR and DSC confirmed no adverse drug-excipient interactions.. Optimized tablets with 5% starch humate achieved a disintegration time of 24 seconds and 99.73% cumulative drug dissolution within 10 minutes.. Pharmacokinetic studies showed a 113.09% relative bioavailability for Telmisartan fast-dissolving tablets formulated with starch humate.
What research method was used?: Experimental design and characterization.
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2025 journal from International Journal of Applied Pharmaceutics.
What should I do differently in my next project?: When developing oral solid dosage forms, consider novel excipients that can improve drug release and absorption, and utilize QbD principles to systematically optimize formulation and manufacturing parameters.
What are the limitations?: The study focused on a single drug (Telmisartan) and a specific formulation type (fast-dissolving tablets). Further research is needed to assess the broader applicability of starch humate across different drugs and dosage forms.